This finding is particularly important given the obesity population's inherent cardiovascular risk
Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
The internet is full of images that range from genuinely impressive clinical documentation to misleading photography that would make any skin look "transformed" regardless of the product used
Schedule at least three consultations
But without stronger oversight, better physician awareness, and a regulatory framework built for the digital marketplace, we may also be building an entirely new class of consumer drugs before we fully understand their consequences
Animal studies have suggested its potential in supporting tissue repair processes in muscle, tendon, and torn ligaments